The mysterious coronavirus outbreak in the Chinese city Wuhan, and its fast spread to many other countries, endanger thousands of lives. The pandemic has catalyzed the drug development for the treatment of SARS-CoV-2. With years of experience in the research of nucleoside analogue inhibitors for the treatment of coronavirus, Creative Biolabs is confident in tailoring BCX4430 (galidesivir) validation service for the treatment of SARS-CoV-2 in a reliable and cost-effective manner. Antiviral Coronavirus https://sars-cov-2.creative-biolabs.com/antiviral-drug-discovery-for-sars-cov2.htm